Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Immune Response Following COVID-19 Vaccination (mRNA or Non-mRNA) in Patients with Relapsing Multiple Sclerosis Treated with the Bruton’s Tyrosine Kinase Inhibitor Evobrutinib: An Update

              Author:Bar-Or, Amit   Cross, Anne H.   Cunningham, Anthony   Hyvert, Yann   Seitzinger, Andrea   Drouin, Elise E.   Alexandri, Nektaria   Tomic, Davorka   Montalban, Xavier   

              Session Name:P2: MS Immunology and Basic Science  

              Topic:MS and Inflammatory Disease  

              Program Number:P2.017  

              Author Institution:Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA  Washington University School of Medicine, St. Louis, MO  The Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia  the healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany  EMD Serono, Billerica, MA  Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany , Eysins, Switzerland  Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain  

              CHANTER Syndrome: A Rare Cause of Encephalopathy and Ischemic Lesions

              Author:Hiana, James   Soh, James   Marchidann, Adrian   

              Session Name:P2: Cerebrovascular Disease and Interventional Neurology: Interesting Cases 1  

              Topic:Cerebrovascular Disease and Interventional Neurology  

              Program Number:P2.017  

              Author Institution:SUNY Downstate Medical Center, Oradell, NJ  Kings County Hospital Center, Brooklyn, NY